1,007 results on '"Itoyama, Yasuto"'
Search Results
2. Induction of Phosphorylated BAD in Motor Neurons After Transient Spinal Cord Ischemia in Rabbits
3. Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis
4. Role of Heme Catabolism in Neurodegenerative Diseases
5. Vascular Endothelial Growth Factor: Protection Against Ischemic Brain Damage with MCA Occlusion in Rats
6. Dendritic cells in muscle lesions of sarcoidosis
7. Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy
8. Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis
9. Functional imaging studies of hyposmia in Parkinson's disease
10. Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis
11. Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey
12. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis
13. Immunocytochemical Localization of P0 Protein in Golgi Complex Membranes and Myelin of Developing Rat Schwann Cells
14. Myelin Basic Protein Demonstrated Immunocytochemically in Oligodendroglia Prior to Myelin Sheath Formation
15. Myelin-Associated Glycoprotein Demonstrated Immunocytochemically in Myelin and Myelin-Forming Cells of Developing Rat
16. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica
17. White matter involvement in idiopathic normal pressure hydrocephalus: a voxel-based diffusion tensor imaging study
18. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice
19. The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
20. Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders
21. Olfactory dysfunction in Parkinson's disease
22. Safety and efficacy of interferon-α in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathy
23. Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features
24. No production results in suspension-induced muscle atrophy through dislocation of neuronal NOS
25. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models
26. Familial Creutzfeldt-Jakob disease with a point mutation (Met to Arg) at codon 232: two different phenotypes
27. Histological evidence of redox system breakdown caused by superoxide dismutase 1 (SOD1) aggregation is common to SOD1-mutated motor neurons in humans and animal models
28. Inflammatory demyelinating polyneuropathy with nephrotic syndrome: Report of a case and review of the literature
29. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B
30. Ophthalmological findings in patients with spinocerebellar ataxia type 1 are not correlated with neurological anticipation
31. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety
32. Altered expression of Th1-type chemokine receptor CXCR3 on CD4 + T cells in myasthenia gravis patients
33. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis
34. Involvement of Activated Microglia in Increased Vulnerability of Motoneurons After Facial Nerve Avulsion in Presymptomatic Amyotrophic Lateral Sclerosis Model Rats
35. Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease
36. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinsonʼs disease: a 3 year longitudinal study
37. Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies
38. Illusory misidentifications and cortical hypometabolism in Parkinsonʼs disease†
39. Association of olfactory dysfunction and brain. Metabolism in Parkinsonʼs disease†
40. Molecular Analyses of the Cu/Zn Superoxide Dismutase Gene in Patients with Familial Amyotrophic Lateral Sclerosis (ALS) in Japan
41. Erratum: FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion
42. In vivo visualization of α-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy
43. Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour
44. Distinct patterns of regional cerebral glucose metabolism in Parkinsonʼs disease with and without mild cognitive impairment
45. Mitochondrial Alterations in Transgenic Mice With an H46R Mutant Cu/Zn Superoxide Dismutase Gene
46. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice
47. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients
48. Oligoclonal IgG bands in Japanese patients with multiple sclerosis. A comparative study between isoelectric focusing with IgG immunofixation and high-resolution agarose gel electrophoresis
49. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-α
50. Development of a High-Throughput Microarray-Based Resequencing System for Neurological Disorders and Its Application to Molecular Genetics of Amyotrophic Lateral Sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.